Although the drug hasn't yet been authorized anywhere, the arrangement with the Medicines Patent Pool could make it available to half the world's population in poor and middle-income countries if approved.
from CBC | Health News https://ift.tt/3oARHw0
Aucun commentaire:
Enregistrer un commentaire